Introduction {#s1}
============

Plasma lipid levels of total cholesterol (CHOL), high-density lipoprotein cholesterol (HDL-C), Low-density lipoprotein cholesterol (LDL-C), and triglycerides (TG), are major contributors to cardiovascular diseases ([@B20]). Current evidence demonstrates that both environmental and genetic factors contribute to these lipid levels. Therefore, discovery of the genetic regulators would be beneficial to determine individual susceptibility to dyslipidemia and eventually for developing gene therapies.

Recent genome wide association studies (GWAS) in humans have linked hundreds of genetic loci to plasma lipid metabolism, including genes *APOE*, *PCSK9*, *CETP*, *LIPC*, *LPL*, and *APOA5* ([@B51]; [@B17]). Furthermore, several rare variants have been uncovered with next generation sequencing technology ([@B33]). Although significant achievements have been made, the identified genetic loci only explain a small portion of the phenotypic variance, suggesting most of the genetic regulators remain unknown.

Mouse models have been widely used for deciphering regulatory genes of quantitative traits. Hundreds of genetic loci have been identified through quantitative trait loci (QTL) mapping in F2 or backcross mouse populations (<http://www.informatics.jax.org/>). However, it's challenging to identify causative genes within QTLs. During the past decade, mouse genetic reference populations, such as BXD recombinant inbred strains ([@B48]), Collaborative Cross ([@B7]), Hybrid Mouse Diversity Panel ([@B13]), and chromosome substitution strains (CSSs) ([@B32]), have significantly accelerated the precise QTL mapping and functional gene identification through improved mapping power and resolution ([@B6]). CSSs, which typically involve two inbred strains with significant phenotypic differences, are a panel of inbred strains by backcrossing the donor and recipient parents over 10 generations. The final panel contains the entire genome information of both strains, and each CSS carries one intact donor chromosome in the genetic background of the recipient strain. Therefore, any phenotypic differences between CSSs and recipient strain can be attributed to the substituted chromosome. This allows for easy detection of genes for multi-genic traits and quick identification of QTLs through linkage analysis in F2 population and fine mapping with congenic strains. Previously, we proposed a novel strategy of developing a Chr 1-specific CSS substitution line (C1SL) to dissect the complex traits. With this strategy, Chr 1 of the recipient strain C57BL/6J (B6) was replaced by different wild mice individually ([@B52]; [@B53]). Compared to CSSs, C1SLs are suitable for both association studies and systems genetics analysis.

It is well known that genes do not act in isolation, but interact with one another to regulate complex traits. In addition, co-expressed genes usually have similar biological functions or are involved in same biochemical pathways. Therefore, building gene networks would provide an alternate way to identify potential regulators and gain insight into the underlying mechanisms of lipid metabolism ([@B43]). To date, several algorithms have been developed to construct gene networks ([@B18]), and weighted gene co-expression network analysis (WGCNA) is the most widely used ([@B23]). In addition to constructing gene networks, this method also allows one to summarize hub genes and module eigengenes (MEs). These can be used to subsequently identify trait-associated modules by performing "guilt-by-association" between phenotypes and eigengenes.

Several studies have demonstrated that Chr 1 harbors multiple genetic loci that regulate plasma lipid and glucose levels ([@B35]; [@B24]). In order to identify the casual genes, we measured plasma lipid and fasting glucose levels in C1SLs and quantified transcriptome levels of liver with RNA-seq technique. By combining gene co-expression network analysis with human GWAS and gene functional annotation, several plasma lipid and glucose regulating candidate genes, especially those located on Chr 1, were identified ([**Figure 1**](#f1){ref-type="fig"}).

![Schematic of the methodology. A total of 14 strains (13 C1SLs and one recipient strain B6) were involved in this study. The upper panel shows the characteristics of C1SLs genome background. Orange bars represent B6 chromosome while the others represent different donor chromosomes from wild mice. Blood lipid and fasting glucose levels were measured at 20 weeks of age. Liver gene co-expression network was constructed with WGCNA. The trait-associated modules were identified through testing the association between traits and MEs. The candidate genes were further dominated by integrating human GWAS and HMDC data.](fgene-10-01258-g001){#f1}

Materials and Methods {#s2}
=====================

Mice and Diet {#s2_1}
-------------

All animal procedures were performed in accordance with guidelines of the Laboratory Animal Committee of Donghua University. 13 C1SLs and one B6 strain of adult male mice (an average of seven per strain; n = 97) were housed in a room maintained at 18--22°C with a 12-h light and 12-h dark cycle (6:00 A.M. to 6:00 P.M.). All animals were given a chow diet (M01-F25; Shanghai SLAC Laboratory Animal, Shanghai, China) for eight weeks, then fed with D12450B diet containing 4.3% fat, 19.2% protein, and 67.3% carbohydrate (Research Diets, New Brunswick, USA) until sacrificed by cervical dislocation at 20 weeks of age.

Experiment Measurement {#s2_2}
----------------------

Blood was collected into 1.5-ml tubes with EDTA by retro-orbital bleeding from mice fasted for 4 h in the morning. Blood serum was separated by centrifugation at 2,500*g* for 15 min and frozen at −20°C until performing cholesterol enzymatic assays assay. Enzymatic assays for CHOL, HDL-C, LDL-C, TG, and glucose (GLU) were performed with biochemical blood analyzer (Hitachi 7180; Hitachi, Tokyo, Japan) by Sino-British SIPPR/B&K Lab Animal (Shanghai, China).

RNA Isolation and Quality Control {#s2_3}
---------------------------------

RNA was extracted from liver tissues using RNAiso Plus reagent(TaKaRa Biotechnology, Dalian, China) according to the manufacturer's protocol. RNA quality was analyzed using NanoDrop 2000c and Bioanalyzer. Samples with A260/A280 of 1.8--2.0 and RNA integrity number greater than 8 were subsequently used for sequencing library preparation.

RNA Library Preparation and Sequencing {#s2_4}
--------------------------------------

Twenty nine mRNA samples (two samples per strain except for strain LY) were used for RNA library preparation and sequencing. The poly(A) mRNA isolation was performed using Poly(A) mRNA Magnetic Isolation Module or rRNA removal Kit. The mRNA fragmentation and priming was performed using First Strand Synthesis Reaction Buffer and Random Primers. First strand cDNA was synthesized using ProtoScript II Reverse Transcriptase and the second-strand cDNA was synthesized using Second Strand Synthesis Enzyme Mix. The purified double-stranded cDNA by beads was then treated with End Prep Enzyme Mix to repair both ends and add a dA-tailing in one reaction, followed by a T-A ligation to add adaptors to both ends. Size selection of Adaptor-ligated DNA was then performed using beads, and fragments of ∼420 bp (with the approximate insert size of 300 bp) were recovered. Each sample was then amplified by PCR for 13 cycles using P5 and P7 primers, with both primers carrying sequences which can anneal with flow cell to perform bridge PCR and P7 primer carrying a six-base index allowing for multiplexing. The PCR products were cleaned up using beads, validated using an Qsep100 (Bioptic, Taiwan, China), and quantified by Qubit3.0 Fluorometer (Invitrogen, Carlsbad, USA). Then libraries with different indices were multiplexed and sequenced on Illumina X-ten instrument (Illumina, San Diego, USA) by GENEWIZ (Suzhou, China) according to the manufacturer's instructions. Sequencing was carried out using a 2x150bp paired-end (PE) configuration.

Reads Mapping and Quantification {#s2_5}
--------------------------------

Reads were aligned to the mouse reference genome (GRCm38) using Tophat2 ([@B22]) with default parameters. The Cufflinks program Cuffnorm ([@B47]) was used to generate tables of expression values (Fragments Per Kilobase of transcript per Million mapped reads, FPKM) which were normalized for library size based on GRCm38 gene annotation downloaded from iGenome (<https://support.illumina.com/sequencing/sequencing_software/igenome.html>). Expression data were further filtered to remove genes that had less than 1 FPKM in 20% or more samples and then log-transformed with log2 (FPKM+1).

Weighted Gene Co-Expression Network Analysis (WGCNA) {#s2_6}
----------------------------------------------------

Log2 transformed expression values were analyzed with WGCNA package in R ([@B23]) to construct gene co-expression networks. Briefly, a correlation matrix was obtained by calculating pair-wise Pearson correlation coefficients between all genes across all samples. Then, a soft thresholding power β = 6 was chosen based on scale-free topology (R^2^ \> 0.9) to generate weighted adjacency matrix. The adjacency matrix was further transformed into Topological Overlap Matrix which assesses transcript interconnectedness. Following this, a dissimilarity measure was calculated. Genes were aggregated into modules by hierarchical clustering based on Topological Overlap Matrix and further refined using the dynamic tree cut algorithm. ME is the first principal component of a given module, and it was used to evaluate the module membership, which assessed the importance of genes in the network.

Candidate Gene Analysis Using Publicly Available Resources {#s2_7}
----------------------------------------------------------

We prioritized the candidates using the following public resources:**Human--Mouse: Disease Connection (HMDC)**. This resource included mouse and human gene-trait relationships from several databases, including Mouse Genome Informatics database (MGI), National Center for Biotechnology Information (NCBI), Online Mendelian Inheritance in Man (OMIM), and the Human Phenotype Ontology (HPO).**Human GWAS**. Human GWAS for plasma lipid and fasting glucose levels were obtained from GRASP (<https://grasp.nhlbi.nih.gov>) ([@B27]) and GWAS Catalog (<https://www.ebi.ac.uk/gwas/>) ([@B29]). GRASP includes available genetic association studies with p value \<0.05. GWAS Catalog collects SNP-trait associations with p value \<1 × 10^−6^. In the present study, mapped genes or genes nearest to the marker with p value \< 1 × 10^−4^ were used to looking for overlap with module gene lists.**Gene expression atlas across mouse tissue**. Gene expression profiles for 22 mouse tissues, which were generated by the Mouse ENCODE project using RNA-seq ([@B54]), were queried from NCBI (<https://www.ncbi.nlm.nih.gov/>). We define genes with "high liver expression" as those with an expression level in liver greater than threefold of the mean expression value across the 22 tissues.

Identification of Genetic Variants for the Candidate Genes {#s2_8}
----------------------------------------------------------

Genetic variants between C1SLs and B6 were identified with whole genome sequencing as previously described ([@B53]). Variant annotation was performed using Variant Effect Predictor ([@B31]).

Results {#s3}
=======

C1SLs Exhibits Broad Phenotypic Variability in Plasma Lipid and Fasting Glucose Levels {#s3_1}
--------------------------------------------------------------------------------------

In this study, plasma lipid (CHOL, HDL-C, LDL-C, and TG) and fasting glucose levels of 13 C1SLs and one recipient strain B6 were examined using enzymatic assays ([**Figure 2A**](#f2){ref-type="fig"}). Assay results demonstrate broad phenotypic variability with fold change 1.62 in GLU, 1.55 in CHOL, 1.51 in HDL-C, 2.11 in LDL-C and 1.58 in TG ([**Figures 2B**--**F**](#f2){ref-type="fig"} and [**Supplementary Data S1**](#SM1){ref-type="supplementary-material"}). Compared to the C1Sls, recipient strain B6 showed relatively low levels of GLU, CHOL, HDL-C, and LDL-C and a high level of TG.

![Phenotype distributions across C1SLs and B6. **(A)** Schematic of traits collection **(B**--**F)** Bar plot of plasma lipid and fasting glucose levels across C1SLs and B6 (mean + standard errors). Each bar represents one strain, and the black corresponds to the recipient strain B6.](fgene-10-01258-g002){#f2}

WGCNA Identifies Several Modules Significantly Associated With Plasma Lipid and Fasting Glucose Levels {#s3_2}
------------------------------------------------------------------------------------------------------

We carried out high throughput RNA-seq using Ilumina X-ten platform to comprehensively quantify the gene abundance of liver tissue for 29 samples. A total of \~2.3 billion reads were obtained, ranging from 26 million to 0.42 billion per sample ([**Supplementary Data S2**](#SM2){ref-type="supplementary-material"}). The raw reads were mapped onto the mouse genome with an average of 80% of the read pairs that are properly assigned. Gene expression levels were generated and normalized with Cuffnorm program. Further filtration was applied (See *Materials and Methods*), which resulted in 10,525 genes for subsequent analysis ([**Supplementary Data S3**](#SM3){ref-type="supplementary-material"}).

To identify regulatory genes for plasma lipid and glucose levels. We constructed gene co-expression networks using WGCNA. With the soft-thresholding power parameter (β = 6) determined by the scale-free topology ([**Figures 3A**, **B**](#f3){ref-type="fig"}), a total of 24 modules (after excluding module gray) were identified ([**Figures 3C**, **D**](#f3){ref-type="fig"} and [**Supplementary Data S3**](#SM3){ref-type="supplementary-material"}). The module size (i.e., the total number of genes in a module) varies significantly, ranging from 39 genes in module M5 to 2,141 genes in module M24. Among those modules, M19 (83 genes) is significantly associated with all five traits ([**Figure 3D**](#f3){ref-type="fig"}), while M1 (930 genes), M14 (99 genes), M20 (389 genes), M21 (117 genes) are significantly linked to TG level and M7 (491 genes), M8 (311 genes), and M12 (247 genes) are associated with fasting glucose level ([**Figure 3D**](#f3){ref-type="fig"}).

![Weighted gene co-expression network analysis of liver transcriptomes. **(A)** The soft thresholding index R^2^ (y-axis) as a function of different thresholding power β (x-axis). **(B)** Mean connectivity (y-axis) as a function of the power β (x-axis). **(C)** Twenty four co-expression modules were identiﬁed from the liver RNA-seq dataset. WGCNA cluster dendrogram groups genes (n = 10,520) measured across C1SLs and its recipient strain B6 liver into distinct gene modules (M1--24) deﬁned by dendrogram branch cutting. **(D)** Module-trait associations. Each row corresponds to a module column to a trait. Each cell contains the corresponding correlation and p-value. The table is color-coded by correlation according to the color legend. The hub genes were indicated aside each module.](fgene-10-01258-g003){#f3}

Gene Prioritizing of Trait-Associated Modules {#s3_3}
---------------------------------------------

M19 is the module most significantly associated with all of the traits. There are 83 genes in this module, and 74 are significantly correlated (p \< 0.05) with these traits and MEs simultaneously ([**Supplementary Data S4**](#SM4){ref-type="supplementary-material"}). Gene ontology (biological process) enrichment analysis revealed that these genes are significantly enriched in lipid metabolism and gluconeogenesis regulation ([**Supplementary Data S5**](#SM5){ref-type="supplementary-material"}). In addition, 14 genes are found in human GWAS with p value \<1 × 10^−4^ ([**Figure 4A**](#f4){ref-type="fig"} and [**Supplementary Data S6**](#SM6){ref-type="supplementary-material"}) and 11 genes are known regulators for blood lipid or glucose metabolism ([**Figure 4C**](#f4){ref-type="fig"}). Four of them, *Creg1*, *Abcc3*, *Cyp2b9*, and *Cyp26a1*, are highly expressed in liver ([**Supplementary Figure 1**](#SM9){ref-type="supplementary-material"}). More importantly, the module hub gene, *Tmem176a*, is significantly correlated with blood lipid levels ([**Figure 4B**](#f4){ref-type="fig"} and [**Supplementary Data S4**](#SM4){ref-type="supplementary-material"}) and have been mapped to CHOL in human GWAS with a p value of 2 × 10^−8^ ([**Supplementary Data S6**](#SM6){ref-type="supplementary-material"}).

![Gene prioritization for module M19. **(A)** Human GWAS overlapping genes for module M19. Genes with GWAS p value \<1 × 10^−4^ for blood lipid and fasting glucose levels were retrieved from GRASP and GWAS Catalog. **(B)** Correlations between module M19 hub gene *Tmem176a* and MEs and traits. **(C)** Gene subnetwork for module M19. Green circles represent genes overlapping with human GWAS; blue circles represent genes functionally validated in mouse models; both functionally validated and GWAS overlapping genes are marked with blue rectangles.](fgene-10-01258-g004){#f4}

For other modules associated with TG level (M1, M14, M20, and M21), 505 genes are significantly correlated with TG and their MEs simultaneously ([**Supplementary Data S7**](#SM7){ref-type="supplementary-material"}), 26 genes are found in human GWAS ([**Figure 5A**](#f5){ref-type="fig"} and [**Supplementary Data S6**](#SM6){ref-type="supplementary-material"}), and 40 are essential for TG metabolism ([**Figures 5B**--**E**](#f5){ref-type="fig"}). In addition, six genes, *Egfr*, *Hsd17b13*, *Cyp3a11*, *Arg1*, *Fads2*, and *Ahcy*, are highly expressed in liver ([**Supplementary Figure 1**](#SM9){ref-type="supplementary-material"}).

![Gene prioritization for TG-associated modules. **(A)** Human GWAS overlapping genes for TG-associated modules. Genes with GWAS p value \<1 × 10^−4^ of TG level were retrieved from GRASP and GWAS Catalog. **(B**--**E)** Gene subnetworks for module M1, M14, M20, and M21. The coloring scheme is same as [**Figure 4C**](#f4){ref-type="fig"}.](fgene-10-01258-g005){#f5}

For other modules associated with fasting glucose level (M7, M8, and M12), 377 genes are significantly associated with fasting glucose and their MEs simultaneously ([**Supplementary Data S8**](#SM8){ref-type="supplementary-material"}). Among them, eight genes are found in human in GWAS ([**Figure 6A**](#f6){ref-type="fig"} and [**Supplementary Data S6**](#SM6){ref-type="supplementary-material"}), and 27 genes are known glucose metabolism regulators ([**Figures 6B**--**D**](#f6){ref-type="fig"}). Furthermore, three of them, *Pck1*, *Fads1*, and *Gckr*, are highly expressed in liver ([**Supplementary Figure 1**](#SM9){ref-type="supplementary-material"}).

![Gene prioritization for fasting glucose-associated modules. **(A)** Human GWAS overlapping genes for fasting glucose-associated modules. Genes with GWAS p value \<1 × 10^−4^ of fasting glucose level were retrieved from GRASP and GWAS Catalog. **(B**--**D)** Gene subnetworks for module M7, M8, and M12. The coloring scheme is same as [**Figure 4C**](#f4){ref-type="fig"}.](fgene-10-01258-g006){#f6}

Prioritizing Causative Genes on Chr 1 {#s3_4}
-------------------------------------

Due to the fact that C1SLs only differ from B6 strain by one chromosome ([**Figure 1**](#f1){ref-type="fig"}), we believe the phenotypic differences are partly driven by the genetic variations on Chr 1. In this study, a total of 38 genes in the trait-associated modules were found to be located on Chr 1. Of which, 35 harbor missense single nucleotide polymorphisms (SNPs), and all have 3' or 5' UTR variants ([**Table 1**](#T1){ref-type="table"}). In addition, several genes have been associated with the traits in mouse models, including *Creg1* and *Aox1* in module M19; *Phlpp1*, *Nr5a2*, *Rnf149*, *Ncoa2*, and *Abl2* in module M1; *Mogat1*, *Igfbp2*, and *Col3a1* in module M20; *G0s2*, *Crp*, and *Ppox* in module M21, M7, and M12, respectively.

###### 

Lists of the module-trait associated genes on Chr 1.

  Gene symbol       Entrez ID    Chr     Start           End             Module    Associated traits             \# Missense SNP   \# UTR SNP
  ----------------- ------------ ------- --------------- --------------- --------- ----------------------------- ----------------- ------------
  ***Creg1***       **433375**   **1**   **165763746**   **165775308**   **M19**   **CHOL, HDL, LDL, TG, GLU**   **1**             **118**
  *Atic*            108147       1       71557150        71579631        M19       CHOL, HDL, LDL, TG, GLU       4                 31
  ***Aox1***        **11761**    **1**   **58029931**    **58106413**    **M19**   **CHOL, HDL, LDL, TG, GLU**   **18**            **5**
  *Smyd3*           69726        1       178951960       179518041       M19       CHOL, HDL, LDL, TG, GLU       10                152
  *Igsf8*           140559       1       172261641       172319841       M19       CHOL, HDL, LDL, TG, GLU       7                 29
  *Inpp4a*          269180       1       37299865        37410736        M1        TG                            39                98
  ***Phlpp1***      **98432**    **1**   **106171752**   **106394250**   **M1**    **TG**                        **9**             **20**
  *Eprs*            107508       1       185363044       185428360       M1        TG                            14                7
  *Ino80d*          227195       1       62958418        63114667        M1        TG                            36                231
  ***Nr5a2***       **26424**    **1**   **136842571**   **136960448**   **M1**    **TG**                        **5**             **93**
  ***Rnf149***      **67702**    **1**   **39551296**    **39577405**    **M1**    **TG**                        **2**             **15**
  ***Ncoa2***       **17978**    **1**   **13139105**    **13374083**    **M1**    **TG**                        **6**             **59**
  ***Abl2***        **11352**    **1**   **156558786**   **156649568**   **M1**    **TG**                        **5**             **113**
  *Kmo*             98256        1       175620381       175662116       M1        TG                            20                105
  *Myo1b*           17912        1       51749765        51916071        M1        TG                            4                 78
  *Wdr26*           226757       1       181173228       181211552       M1        TG                            3                 100
  *Rabgap1l*        29809        1       160219174       160793211       M1        TG                            16                62
  *Sde2*            208768       1       180851127       180868113       M1        TG                            21                28
  *Gm38394*         NA           1       133619940       133661318       M1        TG                            6                 112
  *1700034P13Rik*   73331        1       9747648         9791924         M1        TG                            0                 0
  *Etnk2*           214253       1       133363572       133380336       M14       TG                            12                62
  ***Mogat1***      **68393**    **1**   **78510991**    **78538173**    **M20**   **TG**                        **0**             **3**
  ***Igfbp2***      **16008**    **1**   **72824503**    **72852474**    **M20**   **TG**                        **0**             **5**
  *Cps1*            227231       1       67123026        67231259        M20       TG                            1                 11
  ***Col3a1***      **12825**    **1**   **45311538**    **45349706**    **M20**   **TG**                        **2**             **10**
  *Rpl28-ps1*       100042670    1       128038569       128038982       M20       TG                            0                 0
  *Aox3*            71724        1       58113130        58200698        M20       TG                            14                35
  *2810459M11Rik*   72792        1       86045863        86055456        M20       TG                            6                 56
  ***G0s2***        **14373**    **1**   **193272161**   **193273217**   **M21**   **TG**                        **0**             **7**
  *Mrps9*           69527        1       42851233        42905683        M21       TG                            5                 22
  ***Crp***         **12944**    **1**   **172698055**   **172833031**   **M7**    **GLU**                       **2**             **10**
  *Ppil3*           NA           1       82233112        82235933        M7        GLU                           6                 40
  *Tmem131*         56030        1       36792194        36943666        M7        GLU                           16                19
  *Tmem185b*        226351       1       119526160       119528983       M7        GLU                           1                 26
  *Tex30*           75623        1       44086613        44102441        M7        GLU                           0                 24
  *9430016H08Rik*   70225        1       58430994        58445486        M7        GLU                           0                 0
  *Gm9747*          68115        1       57406328        57417953        M7        GLU                           1                 10
  ***Ppox***        **19044**    **1**   **171275990**   **171281186**   **M12**   **GLU**                       **9**             **10**

Bold highlighted genes are known functional genes.

Discussion {#s4}
==========

Recent work has demonstrated that gene co-expression network analysis is a powerful way to associate genes with specific phenotypes. Here, WGCNA was applied to investigate liver transcriptomes of C1SL mice. A total of 24 modules were identified, with module M19 being significantly associated with blood lipid and glucose levels ([**Figure 3D**](#f3){ref-type="fig"}). Searching MGI database revealed that 13% (11 out of 84) of M19 genes are involved in blood lipid or glucose metabolism ([**Figure 4C**](#f4){ref-type="fig"}), such as acyl-CoA thioesterase 11 (*Acot11*) ([@B56]), cellular repressor of E1A-stimulated genes 1 (*Creg1*) ([@B45]), carboxylesterase 1E (*Ces1e*) ([@B49]), carboxylesterase 1G (*Ces1g*) ([@B49]), and lamin A (*Lmna*) ([@B2]). This suggests that glucose and lipid metabolism share common genetic architecture ([@B36]). We also identified several TG (M1, M14, M20, and M21) and fasting glucose (M7, M8, and M12) associated modules. These modules include several known functional genes ([**Figures 5**](#f5){ref-type="fig"} and [**6**](#f6){ref-type="fig"}), such as peroxisome proliferator activated receptor gamma (*Pparg*) ([@B16]), cell death-inducing DFFA-like effector c (*Cidec*) ([@B46]), monoacylglycerol O-acyltransferase 1 (*Mogat1*) ([@B1]), glucokinase regulatory protein (*Gckr*) ([@B10]), and phosphoenolpyruvate carboxykinase 1(*Pck1*) ([@B15]). Since co-expressed genes are assumed to be involved in interconnected biological pathways ([@B50]), we believe other genes, along with the known functional genes in the trait-associated modules, also serve regulatory roles in glucose and lipid metabolism.

Human GWAS in relation to blood lipid and glucose metabolism have identified hundreds of associated genes ([@B20]; [@B21]; [@B9]; [@B51]; [@B19]; [@B40]). However, most variants identified so far only explain a small portion of phenotypic variance, leaving the majority of heritability unexplained ([@B30]). The inability to uncover the remaining spectrum of variance is related to multiple factors, including sample size, genetic structure, rare variants, and gene-gene interactions ([@B30]; [@B37]). In addition, stringent thresholds of p-value with high multiple testing corrections is also believed to exclude many positive signals ([@B25]; [@B26]). Joint analysis of human GWAS and mouse genetics would help to "rescue" some of the 'missing' heritability ([@B37]; [@B4]; [@B3]; [@B48]). In the present study, we identified 48 genes in the trait-associated modules which have been reported in human GWAS with p value \<1 × 10^−4^. Among them, several genes not only achieved GWAS significance threshold (p value \<5 × 10^−8^), but also functionally validated in mouse models, including acyl-CoA thioesterase 11 (*Acot11*) ([@B5]; [@B56]), estrogen receptor 1(*Esr1*) ([@B34]; [@B5]), Cd36 molecule (*Cd36*) ([@B14]; [@B5]), fatty acid desaturase 2 (*Fads2*) ([@B42]; [@B44]), phospholipase A2, group VI (*Pla2g6*) ([@B55]; [@B41]), glucokinase regulatory protein (*Gckr*) ([@B10]; [@B39]), and fatty acid desaturase 1 (*Fads1*) ([@B39]). Furthermore, we also found several functionally validated genes with modest GWAS p values, such as cellular repressor of E1A-stimulated genes 1 (*Creg1*) ([@B38]; [@B45]), cytochrome P450 family 7 subfamily b polypeptide 1 (*Cyp7b1*) ([@B28]; [@B8]), NAD(P)H dehydrogenase quinone 1 (*Nqo1*) ([@B12]; [@B5]), peroxisome proliferator activated receptor gamma (*Pparg*) ([@B16]; [@B44]), and phosphoenolpyruvate carboxykinase 1(*Pck1*) ([@B15]; [@B9]). Although the function of other genes (GWAS p value \> 5 × 10^−8^) in plasma lipid or glucose metabolism remain unclear, they are possible candidates based on the genetic evidence from our results ([**Figures 4**](#f4){ref-type="fig"}--[**6**](#f6){ref-type="fig"}). Therefore, we believe that by intergrating human GWAS and mouse genetics studies, it is possible to identify more functional genes and uncover part of the 'missing' heritabilities caused by stringent statistical thresholds in human GWAS.

C1SLs are aimed to identify genes associated with complex traits on Chr 1 by performing association studies or systems genetics analysis. However, the current study only included 13 C1SLs and one recipient strain B6 and performing association studies in such a small number of strains could result in many false positives due to the low statistical power ([@B11]). Therefore, we used the systems genetics strategy, gene co-expression network analysis, to prioritize the novel candidate genes-especially those located on Chr 1. A total of 38 Chr 1 genes are found in the eight trait-associated modules with an average of 4.75 genes in each. This number is far less than QTL genes identified by linkage studies in F2 mouse segregation population or association studies in mouse reference populations ([@B6]). In addition, we found at least one gene for each module that has been implicated in regulation of plasma lipid or glucose metabolism ([**Table 1**](#T1){ref-type="table"}). Therefore, this approach could allow for identification of functional genes (Chr 1) more efficiently than using previous methods and mouse population.

In summary, we identified eight gene networks associated with blood lipid and glucose levels by performing gene co-expression network analysis in C1SL mice population. Further joint analysis of human GWAS resulted in 48 candidate functional genes. In addition, 38 genes on Chr 1, including 13 well characterized genes, are prioritized as causative genes. However, these genes still need further studies to illustrate their potential functional roles. With the development of other C1SLs and further achiving of sequencing data, Co-expression network analysis on C1SLs can provide us a new avenue for identifying other causative genes for complex traits on Chr 1.
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